These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21816248)

  • 1. The cost of vision loss in Canada. 1. Methodology.
    Gordon KD; Cruess AF; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):310-4. PubMed ID: 21816248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss.
    Javitt JC; Zhou Z; Willke RJ
    Ophthalmology; 2007 Feb; 114(2):238-45. PubMed ID: 17270673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense.
    Taylor HR
    Am J Ophthalmol; 2007 Jan; 143(1):1-8. PubMed ID: 17188039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of visual impairment and blindness in the United States.
    Frick KD; Gower EW; Kempen JH; Wolff JL
    Arch Ophthalmol; 2007 Apr; 125(4):544-50. PubMed ID: 17420375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Eye Injury in the United States, Estimates from a Meta-Analysis.
    Swain T; McGwin G
    Ophthalmic Epidemiol; 2020 Jun; 27(3):186-193. PubMed ID: 31847651
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
    Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cost of major eye diseases to Medicare, 1991 to 2000.
    Salm M; Belsky D; Sloan FA
    Am J Ophthalmol; 2006 Dec; 142(6):976-82. PubMed ID: 17157582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in adult blindness and low vision, Central Ethiopia.
    Woldeyes A; Adamu Y
    Ethiop Med J; 2008 Jul; 46(3):211-8. PubMed ID: 19271384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and causes of blindness and low vision in Timor-Leste.
    Ramke J; Palagyi A; Naduvilath T; du Toit R; Brian G
    Br J Ophthalmol; 2007 Sep; 91(9):1117-21. PubMed ID: 17709584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A; Zlateva G; Xu X; Rochon S
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A prevalence investigation of blindness and vision impairment in 2009 in older adults of Dachang Blocks of Baoshan District, Shanghai, China].
    Tong XW; Zhao R; Zou HD; Zhu JF; Wang J; Yu J; Wang W; He XG; Lu HH; Zhao HJ; Wang WB
    Zhonghua Yan Ke Za Zhi; 2011 Sep; 47(9):785-90. PubMed ID: 22177122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of low vision and blindness in Canada.
    Maberley DA; Hollands H; Chuo J; Tam G; Konkal J; Roesch M; Veselinovic A; Witzigmann M; Bassett K
    Eye (Lond); 2006 Mar; 20(3):341-6. PubMed ID: 15905873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of blindness and low vision in Bayelsa State, Nigeria: a clinic based study.
    Richard AI
    Nig Q J Hosp Med; 2010; 20(3):125-8. PubMed ID: 21033320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.